Massachusetts Institute of Technology;The Children's Medical Center Corporation
发明人:
ANDERSON, Daniel G.,GU, Zhen,AIMETTI, Alex Arthur,LANGER, Robert S.
申请号：
EP14792285
公开号：
EP2991673A4
申请日:
2014.04.29
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
A system for &ldquo；smart&rdquo； delivery of a therapeutic, prophylactic or diagnostic agent, such as glucose-mediated delivery of insulin through an injectable nano-network consisting of oppositely-charged dextran nanoparticles encapsulating insulin and glucose-specific enzymes forming a gel-like 3D scaffold. As demonstrated by the examples, the system effectively dissociates to release insulin in a hyperglycemic condition, where the catalytic conversion of glucose into gluconic acid and the subsequent degradation of polymeric matrix are facilitated. This formulation design provides a delivery strategy for both self-regulated and long-term diabetes management.
